ACM
IRMD icon

Ativo Capital Management’s iRadimed IRMD Stock Holding History

Ativo Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-68,847
Closed -$764K – 232
2016
Q4 		$764K Buy
68,847
+11,100
+19% +$120K 0.18% 200
2016
Q3 		$981K Buy
57,747
+400
+0.7% +$7.41K 0.23% 153
2016
Q2 		$1.25M Buy
57,347
+36,340
+173% +$654K 0.3% 104
2016
Q1 		$402K Buy
+21,007
New +$402K 0.11% 175

Other funds holding IRMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
MERSOM
Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MC
Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return

Ativo Capital Management's IRMD Position: Q1 2017 in Review

Ativo Capital Management sold out of iRadimed (IRMD) in Q1 2017, closing a stake of 68,847 shares — an estimated $764K sold.

Ativo Capital Management first reported a position in IRMD in Q1 2016 and held it in 4 quarters. The position peaked at $1.25M in Q2 2016. 46 funds tracked by Wall St. Rank hold IRMD as of Q1 2017.

  • Ativo Capital Management reported no remaining iRadimed position as of Q1 2017 after selling out during the quarter.
  • Ativo Capital Management sold 68,847 iRadimed shares in Q1 2017, an estimated $764K.
  • Ativo Capital Management first reported a position in iRadimed in Q1 2016 and held it in 4 quarters.
  • Ativo Capital Management's iRadimed position peaked at $1.25M in Q2 2016.
  • 46 funds tracked by Wall St. Rank held iRadimed as of Q1 2017.

Based on Ativo Capital Management's 13F filing for Q1 2017, filed 12 May 2017.